Detalhe da pesquisa
1.
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity.
J Med Chem
; 66(1): 577-595, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538027
2.
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
PLoS One
; 15(12): e0243901, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378376